Fighting Poor Quality Medicines: Development, Transfer and Validation of Generic HPLC Methods for Analyzing Two WHO Recommended Antimalarial Tablets
Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53394#.VMBv_yzQrzE
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53394#.VMBv_yzQrzE
Author(s)
Jérémie Kindenge Mbinze1,2, Achille Yemoa1,3, Pierre Lebrun1, Pierre-Yves Sacré1, Védaste Habyalimana1,4, Nicodème Kalenda1,2, André Bigot3, Eugène Atindehou5, Philippe Hubert1, Roland Djang’eing’a Marini1
Affiliation(s)
1University of Liege (ULg), Department of Pharmacy, CIRM, Laboratory of Analytical Chemistry, Liège, Belgium.
2Laboratoire d’Analyse des Médicaments, Département de Galénique et d’Analyse des Médicaments, Université de Kinshasa, Kinshasa XI, Democratic Republic of Congo.
3UFR Pharmacie, Faculté des Sciences de Santé, Université d’Abomey Calavi, Cotonou, Bénin.
4Rwanda Biomedical Center, Medical Procurement and Production Division, Butare, Rwanda.
5Université Félix Houphouet Boigny, Abidjan, Côte d’Ivoire.
2Laboratoire d’Analyse des Médicaments, Département de Galénique et d’Analyse des Médicaments, Université de Kinshasa, Kinshasa XI, Democratic Republic of Congo.
3UFR Pharmacie, Faculté des Sciences de Santé, Université d’Abomey Calavi, Cotonou, Bénin.
4Rwanda Biomedical Center, Medical Procurement and Production Division, Butare, Rwanda.
5Université Félix Houphouet Boigny, Abidjan, Côte d’Ivoire.
ABSTRACT
As serious but neglected public health problems, poor quality medicines, i.e.
for antimalarial medicines, urged to be fought. One of the approaches
is to consider the analytical chemistry and separative techniques. In
this study, a generic liquid chromatographic method was firstly
developed for the purpose of screening 8 antimalarial active
ingredients, namely amodiaquine (AQ), piperaquine (PPQ), sulfalene (SL),
pyrimethamine (PM), lumefantrine (LF), artesunate (AS), artemether (AM)
and dihydroartemisinine (DHA) by applying DoE/DS optimization strategy.
Since the method was not totally satisfying in terms of peak
separation, further experiments were undergone applying the same
development strategy while splitting the 8 ingredients into five groups.
Excellent prediction was observed prior to correlation between
retention times of predicted and observed separation conditions. Then, a
successful geometric transfer was realized to reduce the analysis time
focusing on the simultaneous quantification of two WHO’s recommended
ACTs in anti-malarial fixed-dose combination (AM-LF and AS-AQ) in
tablets. The optimal separation was achieved using an isocratic elution
of methanol-ammonium formate buffer (pH 2.8; 10 mM) (82.5:17.5, v/v) at
0.6 ml/min through a C18 column (100 mm × 3.5 mm, 3.5 μm) thermostated
at 25℃. After a successful validation stage based on the total error
approach, the method was applied to determine the content of AM/LF or
AS/AQ in seven brands of antimalarial tablets currently marketed in
West, Central and East Africa. Satisfying results were obtained compared
to the claimed contents.
KEYWORDS
Antimalarial, ACT, Simultaneous Determination, Poor Quality Substances, Design of Experiments, Design Space, Method Transfer, Accuracy Profile
Cite this paper
References
Mbinze,
J. , Yemoa, A. , Lebrun, P. , Sacré, P. , Habyalimana, V. , Kalenda, N.
, Bigot, A. , Atindehou, E. , Hubert, P. and Marini, R. (2015) Fighting
Poor Quality Medicines: Development, Transfer and Validation of Generic
HPLC Methods for Analyzing Two WHO Recommended Antimalarial Tablets. American Journal of Analytical Chemistry, 6, 127-144. doi: 10.4236/ajac.2015.62012.
| [1] | World Health Organization (2013) World Malaria Report 2013. WHO Press, Geneva. |
| [2] | Malaria Consortium (2014) Artemisinin-Based Combination Therapy. http://www.malariaconsortium.org |
| [3] | World Health Organization (2014) Substandard and Counterfeit Medicines. http://www.who.int/mediacentre/factsheets/2003/fs275/en/ |
| [4] | Newton,
P.N., Dondorp, A., Green, M., Mayxay, M. and White, N.J. (2003)
Counterfeit Artesunate Antimalarials in Southeast Asia. Lancet, 362,
169. http://dx.doi.org/10.1016/S0140-6736(03)13872-X |
| [5] | Mbinze,
J.K., Dispas, A., Lebrun, P., Mavar Tayey Mbay, J., Habyalimana, V.,
Kalenda, N., Rozet, E., Hubert, P. and Marini, R.D. (2013) Application
of an Innovative Design Space Optimization Strategy to the Development
of LC Methods for the Simultaneous Screening of Antibiotics to Combat
Poor Quality Medicines. Journal of Pharmaceutical and Biomedical
Analysis, 85, 83-92. http://dx.doi.org/10.1016/j.jpba.2013.06.036 |
| [6] | Mbinze,
J.K., Lebrun, P., Debrus, B., Dispas, A., Kalenda, N., Mavar Tayey
Mbay, J., Schofield, T., Boulanger, B., Rozet, E., Hubert, Ph. and
Marini, R.D. (2012) Application of Aninnovative Design Space
Optimization Strategy to the Development of Liquid Chromatographic
Methods to Combat Potentially Counterfeit Nonsteroidal Anti-Inflammatory
Drugs. Journal of Chromatography A, 1263, 113-124. http://dx.doi.org/10.1016/j.chroma.2012.09.038 |
| [7] | Habyalimana, V., Kalenda Tshilombo, N., Dispas, A., Mbinze, J.K., Kadima Ntokamunda, J.L., Lebrun, P., Hubert, P. and Marini Djang’eing’a, R. (2014) Méthodes chromatographiques génériques de criblage pour lutter contre les médicaments de qualité inférieure. Spectra Analyse, 298, 30-36. |
| [8] | Debrus,
B., Lebrun, P., Kindenge, J.M., Lecomte, F., Ceccato, A., Caliaro, G.,
Mbay, J.M., Boulanger, B., Marini, R.D., Rozet, E. and Hubert, Ph.
(2011) Innovative High-Performance Liquid Chromatography Method
Development for the Screening of 19 Antimalarial Drugs Based on a
Generic Approach, Using Design of Experiments, Independent Component
Analysis and Design Space. Journal of Chromatography A, 1218, 5205-5215.
http://dx.doi.org/10.1016/j.chroma.2011.05.102 |
| [9] | International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q8 (R2) (2009) Pharmaceutical Development. Geneva. |
| [10] | Lebrun,
P., Govaerts, B., Debrus, B., Ceccato, A., Caliaro, G., Hubert, Ph. and
Boulanger, B. (2008) Development of a New Predictive Modeling Technique
to Find with Confidence Equivalence Zone and Design Space of
Chromatographic Analytical Methods. Chemometrics and Intelligent
Laboratory Systems, 91, 4-16. http://dx.doi.org/10.1016/j.chemolab.2007.05.010 |
| [11] | Dewé,
W., Marini, R.D., Chiap, P., Hubert, P., Crommen, J. and Boulanger, B.
(2004) Development of Response Models for Optimising HPLC Method.
Chemometrics and Intelligent Laboratory Systems, 74, 263-268. http://dx.doi.org/10.1016/j.chemolab.2004.04.016 |
| [12] | Debrus,
B., Lebrun, P., Ceccato, A., Caliaro, G., Rozet, E., Nistor, I.,
Oprean, R., Rupérez, F.J., Barbas, C., Boulanger B. and Hubert, P.
(2011) Application of New Methodologies Based on Design of Experiments,
Independent Component Analysis and Design Space for Robust Optimization
in Liquid Chromatography. Analytica Chimica Acta, 691, 33-42. http://dx.doi.org/10.1016/j.aca.2011.02.035 |
| [13] | Memvanga,
P.B., Mbinze, J.K., Rozet, E., Hubert, P., Préat, V. and Marini, R.D.
(2014) Development of a Liquid Chromatographic Method for the
Simultaneous Quantification of Curcumin, β-Arteether, Tetrahydrocurcumin
and Dihydroartemisinin. Application to Lipid-Based Formulations.
Journal of Pharmaceutical and Biomedical Analysis, 88, 447-456. http://dx.doi.org/10.1016/j.jpba.2013.09.009 |
| [14] | US Pharmacopeia (2014) USP 37-NF 32. www.uspnf.com |
| [15] | International Pharmacopoeia (2007) Working Document QAS/07.197/Rev.1. |
| [16] | Guillarme,
D., Nguyen, D., Rudaz, S. and Veuthey, J.L. (2007) Method Transfer for
Fast Liquid Chromatography in Pharmaceutical Analysis: Application to
Short Columns Packed with Small Particle. Part I: Isocratic Separation.
European Journal of Pharmaceutics and Biopharmaceutics, 66, 475-482. http://dx.doi.org/10.1016/j.ejpb.2006.11.027 |
| [17] | Hubert,
P., Nguyen-Huu, J.J., Boulanger, B., Chapuzet, E., Cohen, N.,
Compagnon, P.A., Dewé, W., Feinberg, M., Laurentie, M., Mercier, N.,
Muzard, G., Valat, L. and Rozet, E. (2007) Harmonization of Strategies
for the Validation of Quantitative Analytical Procedures: A SFSTP
Proposal—Part III. Journal of Pharmaceutical and Biomedical Analysis,
45, 82-96. http://dx.doi.org/10.1016/j.jpba.2007.06.032 |
| [18] | Hubert,
P., Nguyen-Huu, J.J., Boulanger, B., Chapuzet, E., Cohen, N.,
Compagnon, P.A., Dewé, W., Feinberg, M., Laurentie, M., Mercier, N.,
Muzard, G., Valat, L. and Rozet, E. (2008) Harmonization of Strategies
for the Validation of Quantitative Analytical Procedures: A SFSTP
Proposal: Part IV. Examples of Application. Journal of Pharmaceutical
and Biomedical Analysis, 48, 760-771. http://dx.doi.org/10.1016/j.jpba.2008.07.018 |
| [19] | Food and Drug Administration (1995) International Conference on Harmonization: Guideline on Validation of Analytical Procedures: Definitions and Terminology. Federal Register, 60, 11260-11262 |
| [20] | Hubert, P., Nguyen-Huu, J.J., Boulanger, B., Chapuzet, E., Chiap, P., Cohen, N., Compagnon, P.A., Dewe, W., Feinberg, M., Lallier, M., Laurentie, M., Mercier, N., Muzard, G., Nivet, C. and Valat, L. (2003) Validation des procédures analytiques quantitatives Harmonisation des démarches. STP Pharma Pratiques, 13, 101-138. |
| [21] | Boulanger,
B., Rozet, E., Moonen, F., Rudaz, S. and Hubert, P. (2009) A Risk-Based
Analysis of the AAPS Conference Report on Quantitative Bioanalytical
Methods Validation and Implementation. Journal of Chromatography B, 877,
2235-2243. http://dx.doi.org/10.1016/j.jchromb.2009.06.019 |
| [22] | The European Medicines Agency (1996) Note for Guidance on Manufacture of the Finished Dosage Form. www.ema.europa.eu/docs/en_GB/document_library/ Scientific_guideline/2009/09/WC500002916.pdf eww150122lx |
评论
发表评论